(Q37146227)

English

Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study

scientific article published on 28 July 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

0 references

1 reference

based on heuristic

inferred from title

ankylosing spondylitis

1 reference

based on heuristic

inferred from title

anterior uveitis

1 reference

based on heuristic

inferred from title

author name string

M Rudwaleit

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

E Rødevand

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

P Holck

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

J Vanhoof

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

M Kron

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

S Kary

6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

H Kupper

7

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

language of work or name

0 references

publication date

28 July 2008

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

68

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

696-701

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663712

6 September 2017

Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663712

6 September 2017

Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663712

6 September 2017

Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663712

6 September 2017

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663712

6 September 2017

First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663712

6 September 2017

Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663712

6 September 2017

Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663712

6 September 2017

International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663712

6 September 2017

Recurrent uveitis in a patient with juvenile spondyloarthropathy associated with tumour necrosis factor alpha inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663712

6 September 2017

Anti-TNF therapy for eye involvement in spondyloarthropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663712

6 September 2017

Staging of patients with ankylosing spondylitis: a preliminary proposal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663712

6 September 2017

Ophthalmologic manifestations of rheumatic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663712

6 September 2017

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663712

6 September 2017

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663712

6 September 2017

Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663712

14 September 2017

Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663712

3 September 2018

Does etanercept induce uveitis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663712

3 September 2018

Efficacy of Etanercept in Preventing Relapse of Uveitis Controlled by Methotrexate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2663712

3 September 2018

Undiagnosed spondyloarthropathy in patients presenting with anterior uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18662932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18662932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18662932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18662932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of the spondyloarthritides in patients with uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18662932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18662932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-TNF therapies in the management of acute and chronic uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18662932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Favorable response to high-dose infliximab for refractory childhood uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18662932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18662932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrent new-onset uveitis in a patient with rheumatoid arthritis during anti-TNFalpha treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18662932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab therapy for the treatment of refractory ocular inflammatory disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18662932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do tumor necrosis factor inhibitors cause uveitis? A registry-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18662932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uveitis and tumour necrosis factor blockade in ankylosing spondylitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18662932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sarcoid-related uveitis occurring during etanercept therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18662932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ocular inflammatory disease in patients with RA taking etanercept: is discontinuation of etanercept necessary?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18662932

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ARD.2008.092585

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37146227&oldid=2090365996"